Boulder, CO, United States of America

Rongming Liu

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Celyntra Therapeutics Sa. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rongming Liu. Retrieved from https://idiyas.com/inventor/rongming-liu-hbey6sep

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Genome Editing by Rongming Liu

Introduction

Rongming Liu is an accomplished inventor based in Boulder, CO (US). He has made significant contributions to the field of genome editing, focusing on efficient and specific methods for modifying genetic material. His work has the potential to impact various biological and medical applications.

Latest Patents

Rongming Liu holds a patent titled "Constructs and uses thereof for efficient and specific genome editing." This patent includes embodiments that disclose novel nucleic acid-guided nucleases, guide nucleic acids, and targetable nuclease systems. The methods described in the patent can be utilized for editing the genomes of humans and other species. Notably, the patent outlines techniques such as recursive genetic engineering and trackable genetic engineering methods.

Career Highlights

Rongming Liu is currently associated with Celyntra Therapeutics, where he applies his expertise in genome editing. His innovative approaches have garnered attention in the scientific community, contributing to advancements in genetic research and therapeutic applications.

Collaborations

Rongming Liu collaborates with talented individuals such as Jamie Kershner and Liya Liang. Their combined efforts enhance the research and development initiatives at Celyntra Therapeutics.

Conclusion

Rongming Liu's work in genome editing exemplifies the intersection of innovation and science. His contributions are paving the way for future advancements in genetic engineering and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…